By Dileep Kumar, Prashant Tiwari The book summarizes the role of multiple enzyme targets and strategies to design and develop novel drug candidates for Alzheimer’s disease (AD). It brings together researchers across the globe having varied scientific backgrounds and expertise in a single volume.The chapters highlight current information scientists have unraveled about the origin, pathogenesis and prevention of AD. The contributions consider both established and emerging drug targets viz. Tau proteins, TREM, and microglia. Topics covered in the book include multi-target anti-Alzheimer’s agents, epigenetic modifications, and the role of specific proteins like TMP21 and Tau in AD. A section dedicated to pharmacological treatments discusses the significance of tubulin-modifying enzymes, memantine, and glutamate antagonists. Enzymatic targets for drug discovery are thoroughly examined, focusing on cholinesterase, secretases, and other enzymes. Additionally, the book explores innovative nano-carrier-based drug delivery methods, emphasizing the crucial role of nanotechnology in effective Alzheimer’s treatment.The book aims to inform students and researchers in the field of neuroscience, medicine and pharmacology about current research and biochemical nuances of AD pathogenesis and enzymatic drug targeting strategies.
Product Details
Publisher : Bentham Science Publishers (December 29, 2023)
Language : English
Hardcover : 287 pages
ISBN-10 : 9815136151
ISBN-13 : 978-9815136159


Developability of Biotherapeutics: Computational Approaches
Practical Manual of Histology (PDF)
Diagnostic Electron Microscopy: A Practical Guide to Interpretation and Technique 1st Edition
The Ultimate Esthetics Course: Anterior Composite Compositions
Lippincott's Concise Illustrated Anatomy: Volume 3: Head & Neck
ITI International Team for Implantology Webinar & Video Lectures Package Part-1 (99 Videos)
Clinical Research: From Proposal to Implementation
Genetics: From Genes to Genomes, 7th Edition (PDF) 


Reviews
There are no reviews yet.